ES2555257T3 - Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales - Google Patents

Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales Download PDF

Info

Publication number
ES2555257T3
ES2555257T3 ES11712054.3T ES11712054T ES2555257T3 ES 2555257 T3 ES2555257 T3 ES 2555257T3 ES 11712054 T ES11712054 T ES 11712054T ES 2555257 T3 ES2555257 T3 ES 2555257T3
Authority
ES
Spain
Prior art keywords
protein
amino acids
infant formula
essential amino
formula low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11712054.3T
Other languages
English (en)
Other versions
ES2555257T5 (es
Inventor
Johannes Bernard Van Goudoever
Eline Marleen Van Der Beek
Marieke Abrahamse-Berkeveld
Günther Boehm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43216285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2555257(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Application granted granted Critical
Publication of ES2555257T3 publication Critical patent/ES2555257T3/es
Publication of ES2555257T5 publication Critical patent/ES2555257T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0626—Isoleucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0628—Leucine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/02—Acid
    • A23V2250/06—Amino acid
    • A23V2250/0654—Valine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Dairy Products (AREA)

Abstract

Fórmula infantil que comprende proteínas, carbohidratos digeribles y grasas, donde la proteína comprende aminoácidos de leucina, isoleucina y valina en una proporción en peso leucina:isoleucina:valina entre (1,1-1,5):(0,9- 1,1):1,0, y donde el contenido de proteína es entre 1,3 y 1,9 g proteína/100 kcal.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
L-VALINA 109,7 mg L-ASPARAGINA 0 mg L-CITRULINA 0 mg L-CARNITINA 1,2 mg
Ejemplo 4. Fórmula infantil que comprende aminoácidos de proteínas de leche intactas según la invención.
[0062] COMPONENTE UNIDAD Por 100 kcal
1.
Proteínas (equivalente) g 1,4
2.
Carbohidratos g 11,7
- Azúcares g 11,5
3. Grasas g 5,12
- Saturadas g 2,22
4.
Fibra, dietética g 0,856
5.
Sodio g 25,8
5
D. Propiedades nutricionales
Porcentajes de energía: 10 [0063]
1. Proteínas (equivalente) En%
5,6
2. Carbohidratos
En% 46,4 *
3. Grasas
En% 46,3
4. Fibra
En% 1,7
Total
En% 100
* Incluyendo ácidos orgánicos y polioles
15
E. Composición [0064]
1. Proteínas (equivalente), total
g 1,4
20
- Nitrógeno (Proteína) - Proteína animal g g 0,224 1,428
Proteína de suero de leche
g 0,861
13
imagen12
[0065]
L-Alanina
mg 65,8
L-Arginina mg 46,9
Ácido L-Aspártico / L-mg 116,2
Asparagina
L-Cist(e)ina mg 25,2
Ácido L-Glutámico / L-mg 263,2
Glutamina
Glicina mg 29,4
L-Histidine mg 33,6
L-Isoleucina mg 109,7 (84,7 de proteína)
L-Leucina mg 158,2
L-Lisina mg 136,5
L-Metionina mg 37,1
L-Fenilalanina mg 63,7
L-Prolina mg 110,6
L-Serina mg 86,8
L-Treonina mg 86,8
L-Triptófano mg 23,1
L-Tirosina mg 59,5
L-Valina mg 114.6
(89,6 de proteínas) proporción leucina:isoleucina:valina=1,4:1,0:1,0
15

Claims (1)

  1. imagen1
ES11712054T 2010-03-26 2011-03-25 Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales Active ES2555257T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2010/050156 WO2011119023A1 (en) 2010-03-26 2010-03-26 Low protein infant formula with increased essential amino acids
WOPCT/NL2010/050156 2010-03-26
PCT/NL2011/050207 WO2011119033A1 (en) 2010-03-26 2011-03-25 Low protein infant formula with increased essential amino acids

Publications (2)

Publication Number Publication Date
ES2555257T3 true ES2555257T3 (es) 2015-12-30
ES2555257T5 ES2555257T5 (es) 2022-02-25

Family

ID=43216285

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11712054T Active ES2555257T5 (es) 2010-03-26 2011-03-25 Fórmula infantil baja en proteínas con aumento de los aminoácidos esenciales

Country Status (13)

Country Link
US (3) US8987196B2 (es)
EP (2) EP2552242B2 (es)
CN (2) CN102892309B (es)
BR (1) BR112012024102B1 (es)
DK (2) DK2984942T3 (es)
ES (1) ES2555257T5 (es)
HU (1) HUE025633T2 (es)
MY (2) MY177379A (es)
PH (1) PH12012501842B1 (es)
PL (1) PL2552242T5 (es)
PT (1) PT2552242E (es)
RU (1) RU2559432C2 (es)
WO (2) WO2011119023A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2858628A1 (en) * 2011-12-14 2013-06-20 Nestec S.A. Methods for predicting age-or developmental stage-appropriate foods for children
SG11201405841RA (en) 2012-03-26 2014-10-30 Pronutria Inc Nutritive fragments, proteins and methods
CA2868469A1 (en) 2012-03-26 2013-10-03 Pronutria, Inc. Nutritive fragments, proteins and methods
EP2831098A4 (en) 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS
HK1206764A1 (en) 2012-03-26 2016-01-15 Axcella Health Inc. Nutritive proteins and methods
RU2658979C2 (ru) * 2012-11-23 2018-06-26 Н.В. Нютрисиа Детские смеси, содержащие оптимизированные профили аминокислот
WO2015046183A1 (ja) 2013-09-24 2015-04-02 味の素株式会社 糖アミノ酸およびその用途
SG11201602012RA (en) 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
ES2729757T3 (es) 2013-11-29 2019-11-06 Nestle Sa Uso de composiciones nutritivas que tienen un reducido contenido de proteínas
CN106231924A (zh) 2013-11-29 2016-12-14 雀巢产品技术援助有限公司 按年龄定制的具有不同蛋白质含量的营养组合物
HK1231398A1 (zh) 2014-04-08 2017-12-22 Abbott Laboratories 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2015154259A1 (en) * 2014-04-09 2015-10-15 Nestle (China) Ltd. Gender specific synthetic nutritional compositions and nutritional systems comprising them
US20170105445A1 (en) * 2014-05-19 2017-04-20 N.V. Nutricia Enteral formulations for preterm infants comprising optimised phenylalanine intake levels
CN106659227B (zh) * 2014-05-19 2022-02-11 N·V·努特里奇亚 包含优化的氨基酸谱的配方物
CN104012659B (zh) * 2014-06-26 2016-04-20 中恩（天津）营养科技有限公司 一种用于苯丙酮尿症儿童的配方粉及其制备方法
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
CN107106584A (zh) * 2014-12-08 2017-08-29 格礼卡姆股份公司 用于治疗代谢障碍的合成组合物
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10500179B2 (en) 2015-10-02 2019-12-10 N. V. Nutricia Glycine for use in tolerance induction in allergic patients
WO2017069613A1 (en) * 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
WO2017215721A1 (en) * 2016-06-15 2017-12-21 Glycom A/S Synthetic compositions comprising human milk oligosaccharides for use γν the prevention and treatment of disorders
US20190200624A1 (en) * 2016-08-31 2019-07-04 Martin R. Lange Nutritional compositions and methods of using same
US20200315235A1 (en) * 2016-10-05 2020-10-08 N. V. Nutricia Normalization of the Intestinal Microbiota Composition in Infants or Toddlers Fed with an Amino Acid-Based Nutritional Composition
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
DE102017200007A1 (de) 2017-01-02 2018-07-05 Schott Ag Spritze mit unterschiedlichen Materialien
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
GB2566971B (en) * 2017-09-28 2020-12-02 Mjn Us Holdings Llc Infant formula having decreased protein content
WO2019139754A2 (en) * 2017-12-19 2019-07-18 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compositions and methods for fetal growth
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
CN109527093A (zh) * 2018-12-27 2019-03-29 安徽康博特保健食品有限公司 一种婴幼儿营养包特殊膳食产品及其制备方法
RU2721605C1 (ru) * 2019-11-11 2020-05-21 Общество с ограниченной ответственностью "Ай Кью Витаминная студия" Фармацевтическая композиция для парентерального капельного введения
KR20230154430A (ko) * 2021-02-24 2023-11-08 밀크 케어 컴퍼니, 인코포레이티드 모유 단백질을 함유하는 영아용 조제유
CN113092652B (zh) * 2021-03-19 2022-09-30 浙江工商大学 一种用于评估个体过敏程度的试剂盒
AU2024365830A1 (en) 2023-10-27 2026-04-09 Société des Produits Nestlé S.A. Paediatric formulations for phenylketonuria and tyrosinaemia and specific free amino acid mixture
CN118415243B (zh) * 2024-07-05 2024-11-05 内蒙古伊利实业集团股份有限公司 可改善芳香族氨基酸生物利用度的营养组合物及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697287A (en) 1969-01-28 1972-10-10 Morton Norwich Products Inc Amino acid food composition
US4252822A (en) * 1979-12-26 1981-02-24 Children's Hospital Medical Center Method for treating phenylketonuria
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
DE4042115C2 (de) 1990-12-28 1993-11-25 Milupa Ag Phenylalaninfreie Säuglings- und Kleinkindernahrungsgrundlage und Verfahren zu ihrer Herstellung
CA2143420C (en) * 1992-12-23 1999-01-19 Phyllis J. B. Acosta Medical foods for the nutritional support of infant/toddler metabolic diseases
US5719133A (en) 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US6511696B2 (en) 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
US6503530B1 (en) * 2001-11-01 2003-01-07 Chunghee Kimberly Kang Method of preventing development of severe metabolic derangement in inborn errors of metabolism
US7651716B2 (en) * 2001-12-21 2010-01-26 Wyeth Llc Methods for reducing adverse effects of feeding formula to infants
DE10221403A1 (de) * 2002-05-14 2003-12-04 Kyberg Pharma Vertriebs Gmbh & Diätetische und pharmazeutische Zusammensetzungen, ihre Herstellung und ihre Verwendung
DE112006002215A5 (de) * 2005-08-23 2008-07-03 Leweling, Hans, Dr. Proteinzusammensetzung zur Behandlung von Proteinmangelzuständen
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
EP2415360A3 (en) * 2006-08-29 2012-02-29 Martek Biosciences Corporation Use of DPA(n-6) oils in infant formula
KR20090125758A (ko) * 2007-02-28 2009-12-07 메이지 데어리즈 코포레이션 아미노산 조성물
WO2008118850A2 (en) * 2007-03-23 2008-10-02 Cambrooke Foods, Llc Dietary compositions

Also Published As

Publication number Publication date
US20170181460A1 (en) 2017-06-29
MY177379A (en) 2020-09-14
US9492498B2 (en) 2016-11-15
US20150352178A1 (en) 2015-12-10
EP2552242B1 (en) 2015-09-09
WO2011119033A1 (en) 2011-09-29
CN107821606B (zh) 2021-09-14
EP2552242A1 (en) 2013-02-06
EP2984942B1 (en) 2020-04-22
MY160552A (en) 2017-03-15
WO2011119023A1 (en) 2011-09-29
DK2984942T3 (da) 2020-06-15
CN102892309B (zh) 2016-01-27
US10136668B2 (en) 2018-11-27
PL2552242T5 (pl) 2021-11-08
US20130079276A1 (en) 2013-03-28
PH12012501842A1 (en) 2013-01-07
PH12012501842B1 (en) 2018-02-07
EP2984942A1 (en) 2016-02-17
BR112012024102B1 (pt) 2020-01-28
EP2552242B2 (en) 2021-09-01
HUE025633T2 (en) 2016-04-28
ES2555257T5 (es) 2022-02-25
US8987196B2 (en) 2015-03-24
CN107821606A (zh) 2018-03-23
DK2552242T3 (en) 2015-12-21
PL2552242T3 (pl) 2016-03-31
RU2559432C2 (ru) 2015-08-10
PT2552242E (pt) 2016-01-08
RU2012145528A (ru) 2014-05-20
BR112012024102A2 (pt) 2015-09-01
CN102892309A (zh) 2013-01-23
DK2552242T4 (da) 2021-11-01

Similar Documents

Publication Publication Date Title
Wu Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health
He et al. Amino acid nutrition and metabolism in chickens
MX2013012230A (es) Composiciones nutricionales que tienen a-hica y citrulina y metodos para utilizar las mismas.
JP2010513259A5 (es)
RU2009126763A (ru) Лечение общих расстройств развития
US7645796B2 (en) Amino acid composition promoting collagen synthesis
WO2008081582A1 (ja) 容器詰飲料
JP2011523626A5 (es)
ES2436145T3 (es) Método para disminuir el amargor y mejorar el sabor de leches maternizadas sin proteínas e hidrolizadas
JP2016509994A5 (es)
CA2678807A1 (en) Compositions and methods for controlling the weight of animals
WO2009057775A1 (ja) アミノ酸組成物を含有する疲労防止剤
US20190216902A1 (en) Amino acid composition for collagen formation
EP3298908A2 (en) Protein-based amino acid composition for use prior to exercise
ATE541568T1 (de) Infusionsflüssigkeit zur behandlung der anämie bei dialysepatienten
IN2015DN03883A (es)
PE20151498A1 (es) Composicion nutricional para promover la saciedad
AR067788A1 (es) Proceso para la preparacion de un polipeptido para su uso farmaceutico
JP2019515881A5 (es)
CL2008000520A1 (es) Composicion para suplementar la dieta de rumiantes con una fuente de aminoacidos esenciales protegida contra la accion del rumen que comprende un derivado de imina de un aminoacido esencial y un vehiculo no toxico; procedimiento para proveer lisina p
ZA202305197B (en) Compound preservative composition based on l-amino acid glycan, preparation method therefor and use thereof
TH78673A (th) องค์ประกอบของผลิตภัณฑ์ยาที่มีกรดอะมิโนที่สิ่งมีชีวิตสังเคราะห์ได้เองและวิธีใช้
AR124611A1 (es) Composiciones y métodos para el tratamiento de enfermedades hepáticas asociadas con una o ambas entre hiperamonemia o pérdida muscular
JP5370429B2 (ja) コラーゲン合成促進アミノ酸組成物
Quiniou et al. Utilisation of soybean meal in pig diets can be reduced through the formulation of low crude protein diets based on rapeseed meal and synthetic amino acids, including L-Valine.